Market Tracker

06/28 9:05am ET

Enzo Biochem Inc (NYSE:ENZ)

5.66
Delayed Data
As of Jun 27
 -0.13 / -2.25%
Today’s Change
2.57
Today|||52-Week Range
6.53
+25.78%
Year-to-Date
No recent news for Enzo Biochem Inc.

Today’s Trading

Previous close5.79
Today’s open5.86
Day’s range5.45 - 5.93
Volume347,736
Average volume (3 months)237,808
Market cap$267.9M
Dividend yield--
Data as of 06/27/2016

Growth & Valuation

Earnings growth (last year)+78.26%
Earnings growth (this year)+78.33%
Earnings growth (next 5 years)--
Revenue growth (last year)+1.72%
P/E ratio14.9
Price/Sales1.39
Price/Book6.26

Competitors

 Today’s
change
Today’s
% change
BSTCBiospecifics Technol...-1.08-2.90%
RGNXRegenxbio Inc-1.00-11.11%
ARWRArrowhead Pharmaceut...-0.33-6.03%
NVIVInVivo Therapeutics ...-0.52-8.58%
Data as of 06/27/2016

Financials

Next reporting dateOctober 11, 2016
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$97.6M
Annual profit (last year)-$2.3M
Net profit margin-2.34%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Executive Officer &
Secretary
Elazar Rabbani
President, CFO, Treasurer, Director &
CAO
Barry W. Weiner
Corporate headquarters
New York, New York

Forecasts